Investment Pitch

Name: Canntab has Signed a non-binding LOI with NewCanna S.A.S. of Bogota, Colombia
Uploaded: 05/11/2022 23:32:39
Duration: 00:04:11
Description: Canntab Therapeutics (CSE:PILL) (FSE:TBF1), a Canadian cannabis oral dosage formulation company, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids, has Signed a non-binding Letter of Intent with NewCanna S.A.S. of Bogota, Colombia,

Canntab has Signed a non-binding LOI with NewCanna S.A.S. of Bogota, Colombia

fullscreen